Sridhar Ranganathan, managing director of Allergan, explains how the affiliate revolutionized the ophthalmologic market in India and how it engages with the different stakeholders, ranging from government institutions to the Women Ophthalmologic Society to bring value to the country and help patients.
Can you give our international readers a brief introduction of your background in the pharmaceutical sector?
"India is a land of opportunities and if you do business in the right way you can shape the market and grow significantly."
